Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

Medicare Part D / Prescription Drugs

Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

On May 22, 2020, the Centers for Medicare & Medicaid Services (CMS) published a final rule regarding Medicare Advantage (Medicare Part C) and Part D prescription drug plans (“C & D Rule”). The rule is entitled “Medicare Program; Contract Year … [Read more...] about Final Rule for Medicare Parts C and D Includes Weakened Standards for Medicare Advantage Networks

CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

In a May 26, 2020 press release, the Centers for Medicare & Medicaid Services (CMS) “announced that over 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer … [Read more...] about CMS Announces Voluntary Part D Program to Reduce Insulin Out-of-Pocket Costs for Some Enrollees

Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule

On February 18, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Medicare and Medicaid Programs; Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare … [Read more...] about Center for Medicare Advocacy Submits Comments on Proposed Medicare Parts C and D Rule

House Passes Historic Medicare Expansion Bill – H.R. 3

Today the U.S. House of Representatives passed H.R. 3, The Elijah Cummings Lower Drug Costs Now Act, by a vote of 230 to 192. This bill, if enacted into law, would lead to a significant reduction in prescription drug costs. The resulting savings … [Read more...] about House Passes Historic Medicare Expansion Bill – H.R. 3

Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare

For Immediate Release December 9, 2019 Contact: Kata Kertesz, Esq. – kkertesz@medicareadvocacy.org, 202-293-5760 The Center for Medicare Advocacy, leading Medicare beneficiary experts, call on Congress to pass groundbreaking legislation to … [Read more...] about Medicare Experts Call for Swift Passage of HR3 to Lower Drug Prices and Improve Medicare

Speaker Pelosi Unveils Bill Authorizing Negotiation of Drug Prices and Capping Out-of-Pocket Costs

On September 19, 2019, Representative Frank Pallone, Jr., Chairman of the U.S. House Committee on Energy & Commerce, introduced the Lower Drug Costs Now Act (H.R. 3). As noted in The New York Times, the bill addresses the problem of skyrocketing … [Read more...] about Speaker Pelosi Unveils Bill Authorizing Negotiation of Drug Prices and Capping Out-of-Pocket Costs

Part D Legislation Markup Today: Improve Beneficiary Appeals

On Tuesday, July 23, the Senate Finance Committee released draft drug pricing legislation, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. This sweeping bill would make a number of changes aimed at addressing the high and rising costs of … [Read more...] about Part D Legislation Markup Today: Improve Beneficiary Appeals

Center for Medicare Advocacy Submits Comments to House Ways & Means and Energy & Commerce Committees on Draft Part D Legislation

On May 23, 2019, Ways & Means Committee Chairman Richard E. Neal (D-MA) and Energy & Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), along with Ranking Members Kevin Brady (R-TX) and Greg Walden (R-OR) announced a solicitation for … [Read more...] about Center for Medicare Advocacy Submits Comments to House Ways & Means and Energy & Commerce Committees on Draft Part D Legislation